← Browse by Condition
Medical Condition
hepatic insufficiency
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1
NCT07165002 Phase 1
Recruiting
A Study of the Pharmacokinetics and Safety of LY3537031 in Participants With Normal Liver Function and With Mild, Moderate, or Severe Liver Impairment
Enrollment
32 pts
Location
Hungary, New Zealand...
Sponsor
Eli Lilly and Company
NCT07401862 Phase 1
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Different Levels of Liver Damage and in Participants With Healthy Livers.
Enrollment
36 pts
Location
United States, Hunga...
Sponsor
Eli Lilly and Company